Sonic Fund II, L.P. - Q2 2020 holdings

$201 Million is the total value of Sonic Fund II, L.P.'s 17 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was - .

 Value Shares↓ Weighting
WFC NewWELLS FARGO CO NEW$15,360,000600,000
+100.0%
7.64%
UAL NewUNITED AIRLS HLDGS INC$6,638,000191,785
+100.0%
3.30%
FUN NewCEDAR FAIR L Pdepositry unit$4,125,000150,000
+100.0%
2.05%
EPD NewENTERPRISE PRODS PARTNERS L$3,634,000200,000
+100.0%
1.81%
SEAS NewSEAWORLD ENTMT INC$2,962,000200,000
+100.0%
1.47%
BOOT NewBOOT BARN HLDGS INC$2,156,000100,000
+100.0%
1.07%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ADVERUM BIOTECHNOLOGIES INC12Q3 202247.8%
GENWORTH FINL INC12Q3 202214.5%
FENNEC PHARMACEUTICALS INC12Q3 202213.2%
REGENXBIO INC12Q3 202219.6%
TRONOX HOLDINGS PLC12Q3 20223.3%
SPIRIT AIRLS INC11Q3 20228.7%
US FOODS HLDG CORP11Q3 20227.7%
RADIAN GROUP INC11Q3 20224.1%
HAWAIIAN HOLDINGS INC11Q3 20224.5%
UNITED AIRLS HLDGS INC10Q3 20224.9%

View Sonic Fund II, L.P.'s complete holdings history.

Latest significant ownerships (13-D/G)
Sonic Fund II, L.P. Q2 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Adverum Biotechnologies, Inc.December 30, 20224,552,0684.6%
FENNEC PHARMACEUTICALS INC.February 14, 20222,407,3579.3%

View Sonic Fund II, L.P.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
SC 13D/A2022-12-30
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
SC 13G/A2022-02-14

View Sonic Fund II, L.P.'s complete filings history.

Compare quarters

Export Sonic Fund II, L.P.'s holdings